The Evolving Landscape of Cognitive Function in NF1

Neurofibromatosis type 1 (NF1) is a common autosomal dominant neurocutaneous disorder that presents a diverse range of clinical manifestations. While the physical hallmarks, such as café-au-lait macules and neurofibromas, are well-documented, the cognitive phenotype has historically been studied primarily in pediatric populations. Consequently, many clinicians may underestimate the persistent nature of these challenges as patients transition into adulthood. However, cognitive function in NF1 involves complex impairments in attention, memory, and executive function that can significantly disrupt daily living. Specifically, research has shown that these deficits are not merely developmental delays but may persist or even evolve throughout a patient's lifespan. Therefore, understanding the adult neurocognitive profile is essential for providing comprehensive long-term care. A recent cross-sectional study conducted by Muñoz et al. (2026) has shed new light on this area by examining adults who were previously considered to have no significant cognitive or psychological comorbidities. This approach provides a clearer view of the inherent neurocognitive impact of the NF1 gene mutation itself, free from the confounding effects of intellectual disabilities or severe psychiatric disorders.

Methodology and Domain-Specific Analysis

To characterize the adult cognitive profile accurately, the study recruited eighty-seven adults with NF1 who did not have intellectual disabilities or prior psychiatric diagnoses. Each participant underwent a rigorous standardized neuropsychological assessment. Researchers focused on seven distinct cognitive domains: visual memory, verbal memory, executive function, attention, visuospatial ability, working memory, and visuomotor speed. Furthermore, cognitive performance was standardized using age-adjusted normative Z-scores derived from Spanish reference data. This methodology ensured that the results were comparable to the general population. Notably, the researchers found that adults with NF1 performed below the normative mean across multiple domains. Executive function, in particular, showed clinically significant impairment with an average Z-score of -2.267. In contrast, performance in the attention domain was classified as low-average, with a Z-score of -1.171. These findings suggest that the cognitive burden of NF1 remains substantial in adulthood. Moreover, the selective nature of these deficits implies that clinicians must adopt more targeted screening tools rather than relying on general intelligence assessments. For instance, a patient may possess a normal intelligence quotient yet struggle immensely with complex planning or sustained focus.

Executive Dysfunction: The Core Cognitive Challenge

Executive function is often considered the cornerstone of cognitive function in NF1 research. This domain encompasses a set of mental skills that include working memory, flexible thinking, and self-control. According to the study results, executive dysfunction was the most severely affected area in the adult cohort. Consequently, patients may experience significant difficulties in managing time, organizing professional tasks, and making complex decisions. Although these individuals did not have a history of cognitive disorders, their performance indicates a persistent neurobiological vulnerability. For example, the high level of impairment observed suggests that the underlying pathophysiology of NF1 continues to affect the prefrontal cortex and its associated networks throughout adulthood. Additionally, because executive function is critical for vocational success and social integration, these deficits often translate into functional limitations that may not be immediately apparent during a standard medical consultation. Therefore, physicians should proactively inquire about a patient's ability to handle executive tasks at home and work. Furthermore, recognizing these deficits allows for the implementation of compensatory strategies, such as the use of digital organizers or cognitive behavioral coaching, which can improve the overall quality of life for adult patients.

Attention Deficits and Clinical Correlates

Attention is another vital domain within the broader spectrum of cognitive function in NF1. While the impairment in attention was less severe than that of executive function in the Muñoz et al. study, it still fell into the low-average range. This suggests that while adult NF1 patients may not always meet the full diagnostic criteria for ADHD, they often struggle with sustained concentration and processing speed. Interestingly, the study explored the relationship between these cognitive outcomes and clinical variables. Specifically, attention was significantly associated with skin severity. This correlation suggests that the overall biological burden of the disease may correlate with neurological outcomes, although the exact mechanism remains a subject of ongoing research. Additionally, visuospatial ability was found to be associated with depressive symptoms. However, it is important to note that these psychological symptoms were often subclinical in this specific cohort. Nevertheless, the presence of depressive symptoms, even at low levels, can further exacerbate cognitive challenges. Consequently, a multidisciplinary approach that addresses both physical symptoms and psychological well-being is necessary. For instance, managing dermatological concerns or providing counseling for subclinical mood changes might indirectly support better cognitive performance in daily activities.

Implications for Clinical Practice and Long-Term Management

The findings of this study have profound implications for the management of NF1 in adult patients. First and foremost, clinicians must recognize that cognitive function in NF1 requires lifelong monitoring. In the Indian context, where specialized NF1 clinics may be limited, the responsibility often falls on neurologists and family physicians to identify these subtle deficits. Moreover, the transition from pediatric to adult care is a critical period where many patients lose access to neuropsychological support. Therefore, creating a structured transition plan that includes a baseline adult cognitive assessment is highly recommended. Furthermore, because executive dysfunction is so prevalent, vocational rehabilitation and educational accommodations should not be restricted to children. Adults may also benefit from occupational therapy focused on organizational skills. Additionally, healthcare providers should be aware of the interplay between physical severity and cognitive performance. Regular skin examinations and monitoring for neurofibroma progression are not only important for physical health but may also serve as markers for potential cognitive fluctuations. Finally, fostering patient awareness about the cognitive aspects of NF1 can empower them to seek help for challenges that they might otherwise attribute to personal failings rather than their underlying genetic condition.

Future Directions in NF1 Neuropsychology

As we look toward the future, more longitudinal research is needed to determine how cognitive function in NF1 changes as patients enter late adulthood and senescence. The current study provides a robust cross-sectional snapshot, but it does not account for the potential for age-related cognitive decline in this population. Specifically, researchers should investigate whether the presence of the NF1 mutation increases the risk of early-onset neurodegenerative changes. Furthermore, the development of standardized neuropsychological batteries specifically tailored for adults with NF1 is a priority. These batteries should be culturally and linguistically adapted for diverse populations, including those in India, to ensure accurate diagnosis and intervention. Moreover, emerging pharmacological treatments, such as MEK inhibitors, are currently being evaluated for their impact on plexiform neurofibromas, but their potential role in improving cognitive outcomes is also an exciting area of study. Consequently, the integration of cognitive endpoints into clinical trials for NF1 therapies will be essential. In conclusion, while the physical symptoms of NF1 are often the focus of clinical attention, the cognitive profile is a major determinant of life satisfaction. By adopting a more holistic view of the disorder, medical professionals can significantly improve the long-term outcomes and daily functioning of their adult patients.

Frequently Asked Questions

How does NF1 affect executive function in adults?

Adults with neurofibromatosis type 1 often experience clinically significant impairments in executive function, even without a history of intellectual disability. This dysfunction typically manifests as difficulties with complex planning, organization, and cognitive flexibility. These challenges can persist throughout adulthood, often impacting vocational performance and social interactions. Therefore, clinicians should prioritize the assessment of executive skills as part of routine long-term care for all adult NF1 patients.

Is there a link between physical symptoms and cognitive performance?

Recent research indicates a notable correlation between physical disease markers and cognitive outcomes in NF1. Specifically, increased skin severity has been associated with poorer performance in the attention domain. Additionally, visuospatial deficits have shown a relationship with subclinical depressive symptoms. These findings suggest that the overall biological burden of the disorder may influence neurological health, highlighting the need for a multidisciplinary approach that addresses both physical and mental health.

What should a cognitive screening for an adult with NF1 include?

A comprehensive cognitive screening for adults with NF1 should go beyond general intelligence testing. It is essential to include standardized measures for executive function, sustained attention, and visuospatial memory, as these are the domains most frequently affected. Clinicians should also evaluate the impact of these deficits on daily functioning and professional life. Early identification of these selective impairments allows for targeted interventions and better support for the patient's overall well-being.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Muñoz D et al. Cognitive function in adult NF1 patients without other cognitive disorders: a cross-sectional study. Orphanet J Rare Dis. 2026 Jul 03. doi: 10.1186/s13023-026-04456-6. PMID: 42399989.

Cassina M et al. Executive Function in Adults with Neurofibromatosis Type 1: A Systematic Review. Genes. 2024; 15(2):188. doi: 10.3390/genes15020188.

Stewart DR et al. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018; 20(7):671-682. doi: 10.1038/gim.2018.67.